Vitamin Shoppe Inc. (NYSE:VSI) shares saw unusually-strong trading volume on Friday . Approximately 576,531 shares were traded during mid-day trading, an increase of 151% from the previous session’s volume of 229,264 shares.The stock last traded at $29.26 and had previously closed at $29.51.

Several analysts have issued reports on VSI shares. Robert W. Baird restated a “hold” rating on shares of Vitamin Shoppe in a research report on Tuesday, April 26th. Wedbush began coverage on shares of Vitamin Shoppe in a research report on Wednesday, April 20th. They issued an “outperform” rating and a $39.00 price target on the stock. Zacks Investment Research raised shares of Vitamin Shoppe from a “sell” rating to a “hold” rating and set a $32.00 price objective for the company in a report on Friday, May 6th. Jefferies Group reaffirmed a “hold” rating and set a $32.00 price objective (up from $30.00) on shares of Vitamin Shoppe in a report on Friday, May 6th. Finally, Piper Jaffray Cos. reaffirmed a “neutral” rating and set a $30.00 price objective on shares of Vitamin Shoppe in a report on Friday, April 15th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $32.82.

The company has a market capitalization of $697.30 million and a PE ratio of 16.68. The firm’s 50 day moving average is $30.81 and its 200-day moving average is $29.90.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.02. During the same quarter in the prior year, the firm earned $0.63 earnings per share. The company earned $336.80 million during the quarter, compared to analyst estimates of $339.76 million. Vitamin Shoppe’s revenue for the quarter was up .0% on a year-over-year basis. On average, equities analysts forecast that Vitamin Shoppe Inc. will post $2.32 earnings per share for the current fiscal year.

In related news, Director Guillermo Marmol acquired 1,000 shares of the firm’s stock in a transaction on Tuesday, May 31st. The shares were purchased at an average cost of $30.23 per share, for a total transaction of $30,230.00. Following the completion of the acquisition, the director now directly owns 1,470 shares in the company, valued at $44,438.10. The purchase was disclosed in a filing with the SEC, which is available at this link.

Several institutional investors recently added to or reduced their stakes in VSI. Employees Retirement System of Texas bought a new position in Vitamin Shoppe during the fourth quarter valued at approximately $1,275,000. Principal Financial Group Inc. increased its position in Vitamin Shoppe by 7.4% in the fourth quarter. Principal Financial Group Inc. now owns 199,248 shares of the company’s stock valued at $6,516,000 after buying an additional 13,789 shares in the last quarter. State of Wisconsin Investment Board increased its position in Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock valued at $5,203,000 after buying an additional 1,229 shares in the last quarter. Gabelli Funds LLC increased its position in Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock valued at $1,734,000 after buying an additional 7,000 shares in the last quarter. Finally, Rhumbline Advisers increased its position in Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock valued at $1,475,000 after buying an additional 1,855 shares in the last quarter.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.